A maior rede de estudos do Brasil

Grátis
9 pág.
homeostase glicemica

Pré-visualização | Página 5 de 5

Curr Biol; 12 (7): R236-8, 2002.
36. CRYER, P.E. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol; 264 (2 Pt 1): 
E149-55, 1993.
37. MCCRIMMON, R.J.; SHERWIN, R.S. Hypoglycemia in type 1 diabetes. Diabetes; 59 (10): 2333-9, 2010. 
38. MCCRIMMON, R. The mechanisms that underlie glucose sensing during hypoglycaemia in diabetes. Diabet Med; 25: 513-
522, 2008.
39. ROUTH, V.H. Glucose-sensing neurons: are they physiologically relevant? Physiol Behav; 76: 403-413; 2002.
40. FANELLI, C.; PAMPANELLI, S.; EPIFANO, L. et al. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine 
responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia; 
37: 797-807, 1994.
41. MITRAKOU, A.; RYAN, C.; VENEMAN, T. et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, 
symptoms, and cerebral dysfunction. Am J Physiol; 60: E67-E74, 1991.
42. GAISANO, H.Y.; MACDONALD, P.E.; VRANIC, M. Glucagon secretion and signaling in the development of diabetes. Front 
Physiol; 3: 349, 2012.
43. CRYER, P.E. Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology; 153 
(3): 1039-48, 2012.
44. TESFAYE, N.; SEAQUIST, E.R. Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci; 1212: 12-28, 2010.
45. CRYER, P.E. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes; 43: 1378-1389, 1994.
46. SCHWARTZ, N.S.; CLUTTER, W.E.; SHAH, S.D. et al. Glycemic thresh- olds for activation of glucose counterregulatory systems 
are higher than the threshold for symptoms. J Clin Invest; 79: 777-781, 1987.
47. ROTH, J.; GLICK, S.M.; YALOW, R.S. et al. Hypoglycemia: a potent stimulus to secretion of growth hormone. Science; 140: 
987-988, 1963.

Crie agora seu perfil grátis para visualizar sem restrições.